GlassScriptPhysician profile
Leonard M Cetner
NPI 1477667590
$22,428.19
in general payments reported to CMS, 2019-2025
44 companies · $2,225 in 2025
The $2,225 reported for 2025 was more than what 78% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,925 · 2020: $2,236 · 2021: $3,637 · 2022: $5,695 · 2023: $2,960 · 2024: $2,749 · 2025: $2,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,488 · Education: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,487.65 |
| Education | $446.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $5,305.82 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $2,257.29 | 2019-2025 | Ilumya, Winlevi, Absorica Ld |
| Almirall LLC | $2,044.40 | 2019-2024 | Seysara |
| Abbvie INC. | $2,003.04 | 2019-2025 | Rinvoq, Skyrizi |
| Zerigo Health, INC. | $1,200.00 | 2022 | |
| Genzyme Corporation | $994.49 | 2019-2025 | |
| Galderma Laboratories, L.P. | $994.07 | 2019-2025 | Aklief, Oracea, Epsolay |
| Leo Pharma INC. | $794.84 | 2019-2025 | Adbry |
| Novartis Pharmaceuticals Corporation | $661.69 | 2019-2025 | |
| Lilly USA, LLC | $631.23 | 2020-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $515.90 | 2019-2025 | |
| Ucb, INC. | $481.88 | 2019-2025 | Bimzelx, Cimzia |
| Mayne Pharma Commercial LLC | $442.17 | 2019-2025 | |
| Epi Health, LLC | $401.90 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $383.17 | 2019-2023 | Jublia, Arazlo |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Cetner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.